November 2024 Newsletter, Marquee

November 2024 Newsletter, Marquee

Catalysing Science for a Better Tomorrow: Top news from the hub that's brewing science research and innovation to impact lives in India and beyond.


C-CAMP partners with ICARS in another global collaboration to address Antimicrobial Resistance through One Health

The International Centre for Antimicrobial Resistance Solutions (ICARS) , based out of Denmark, and C-CAMP will jointly strive to fund and support innovative solutions to address the challenge of on Antimicrobial Resistance (AMR) across the One Health domain over the next 5 years of India’s National Action Plan 2.0 (NAP 2.0) on AMR. The partners will mobilise funds to identify, develop and integrate innovative solutions impacting One Health in India and low and middle income countries through an AMR Challenge. These innovations will be supported for on-ground testing, uptake and scale up through public sector networks. Know More

7 Technologies supported by C-CAMP receive the prestigious Indo-US Endowment Award by IUSSTF

7 out of 11 awardees of Indo-US Endowment Award- USISTEF Grants 2024 in the Artificial Intelligence track are from C-CAMP and in the exciting domain of AI in health. Congratulations to our supported startups who received the award. Check out the winning technologies addressing critical gaps in healthcare and transforming lives through AI/ML. Know More

?? Mocxa - portable robotic video EEG solution for diagnosis of seizures ?

?? Rajesh Labs by Dr. Rajesh Palani : pocket medical scanner to diagnose pneumonia & other diseases

?? PAQS Pvt Ltd., : a smart inhaler to enable better asthma management

?? SNRAS SYSYTEMS - recirculatory aquaculture system design and implementation on site

?? Qure.ai : AI-powered solutions enhancing tuberculosis (TB) detection, early detection and management of lung cancer and timely interventions in stroke care

?? Adiuvo Diagnostics Pvt. Ltd. : AI-based assessment technology for complex wounds

?? Docturnal Private Limited : a solution for TB screening and detection

More AMR innovators under C-CAMP-SBI Foundation umbrella

The AMR Challenge by SBI Foundation & C-CAMP has selected 12 finalists across diagnostics, preventatives and management of AMR associated infections. These include Aasya Healthcare, Mylab Discovery Solutions Pvt. Ltd. , Papersens, BabyCue Pvt Ltd , Biomoneta , Savemom, HEALSEQ , Retro Biotech and Research , Achira Labs Pvt. Ltd. & Foundation for Neglected Disease Research , Diagopreutic Private Limited , Chimertech Private Limited and Ariviya . Their innovations target wound management, UTIs, neonatal sepsis, diarrhoea, TB, fevers of unknown origin and bovine mastitis. Know more

Join C-CAMP’s world class bioincubation programme

C-CAMP's multiple award winning bioincubation programme has supported close to 200 innovative start-ups across life-sciences till date. It offers access to high-end technology platforms, plug-and-play lab facilities and to the vibrant entrepreneurial eco-system that we have built at C-CAMP.?

Write to us at incubation[at]ccamp.res.in | Know more

Study by C-CAMP incubated Bugworks on novel antibiotic candidate

Published in Nature communications, this study by Bugworks Research Inc. introduces BWC0977, their novel broad-spectrum antibacterial clinical candidate for treating multidrug-resistant infections. The findings revealed BWC0977's efficacy against a wide range of bacteria, including MDR strains, its pharmacological profile and its potential as a new therapeutic option to fight anti-microbial resistance. Know more

Our startups are going places!

A. Global laurels for Innaccel

Saans, a CPAP device for breathing support in neonates developed by C-CAMP supported InnAccel has been receiving global recognition. It got featured in the Unitaid report as a notable innovation in the global medical oxygen landscape specifically in LMICs. Saans also got selected by the 美国麻省理工学院 Solve Awards 2024 , the only Indian healthcare startup in this year's cohort.

B. Fundraising News

C-CAMP supported Aikenist Technologies has raised funding to enhance the AI capabilities of their QuickSuite platform, a medical imaging platform for diagnosing diseases. Another supported startup Ahammune Biosciences Pvt. Ltd. has raised $5 million in a Series A funding round led by pi ventures to conduct Phase II human clinical trials for their vitiligo drug candidate.

C. Prestigious national award in healthcare innovation

C-CAMP supported EzeRx has won the prestigious Anjani Mashelkar Foundation Prize for their innovative non-invasive haemoglobin testing for rapid, point-of-care detection of anaemia. This is the fourth Anjani Mashelkar Prize for CCAMP-supported startups. EzeCheck, is a portable device that scans the fingertip to measure haemoglobin levels and detects anaemia in less than a minute. Earlier winners include Sascan Meditech, Dozee and Salcit. Know more

Research Services

C-CAMP's 15 state-of-the-art technology platforms are accessible for researchers across academia, startups and industry to help advance complex science, not just across the central of dogma of molecular biology, but also across Medical technology and focus areas in agri-tech & cleantech. The programme also offers customised and novel method development experiments with some of India’s most experienced technical experts.

Access our services across biologics, flow cytometry, imaging facility, next generation genomics, mass spectrometry, microfluidics and microfabrication, protein technology and structural determination

Contact us ?? services[at]ccamp.res.in | Discover our services

Upcoming Events


Centre for Cellular and Molecular Platforms

C-CAMP, GKVK Post, Bellary Road, 560065, Bengaluru | Website: www.ccamp.res.in | Subscribe to all our newsletters - https://www.ccamp.res.in/subscribe | Get in touch: [email protected]

Twitter | LinkedIn | Facebook | Instagram | YouTube | Medium



Thank you for featuring our success in your newsletter; this recognition inspires us to continue driving innovation and making a global impact in the MedTech industry.

要查看或添加评论,请登录

社区洞察

其他会员也浏览了